solution for injection

Product Name Golimumab Solution for Injection 50 mg Brand Simponi® 50 mg Active Ingredient Golimumab 50 mg Dosage Form Solution for injection Route of Administration Subcutaneous administration Product Category Biologic / TNF inhibitor Presentation Single-use pre-filled syringe presentation, subject to market-specific packaging and availability. International Export Markets MEDINDIA EXPORT serves eligible pharmaceutical trade inquiries for international markets, including: USA, UK, Canada, Australia, New Zealand, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Austria, Sweden, Norway, Denmark, Finland, Poland, Ireland, Portugal, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Japan, South Korea, UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Jordan, South Africa, Nigeria, Kenya, Ghana, Tanzania, Egypt, Morocco, Brazil, Mexico, Argentina, Chile, Colombia, Peru, Ecuador, Costa Rica, Panama, and other permitted markets. Packaging & Storage Packaging and product presentation may vary according to the destination market and manufacturer. Biologic medicines should be stored and transported according to the manufacturer's approved conditions, including applicable temperature-control requirements. Buyer & Importer Information This product may be of interest to eligible: Licensed pharmaceutical importers Pharmaceutical distributors Hospitals and healthcare organizations Authorized medical suppliers Licensed wholesalers Pharmaceutical procurement companies Importers must ensure that they hold the appropriate licenses and that the product is legally permitted for import and distribution in the destination country. Pharmaceutical Export from India MEDINDIA EXPORT assists with international pharmaceutical trade inquiries from India. Export transactions are handled subject to applicable Indian pharmaceutical export regulations, destination-country import regulations, product authorization requirements, customs procedures, and documentation requirements. Trading FAQs Q: Is Golimumab 50 mg a prescription medicine? Yes. Golimumab is a prescription biologic medicine and should be supplied and used under appropriate medical supervision. Q: Can Golimumab be exported worldwide? Export and import eligibility depends on the regulations of both India and the destination country. Buyers should verify local requirements before ordering. Q: Does the product require special shipping conditions? Biologic products may require controlled-temperature transportation. The manufacturer's approved storage and transportation requirements should be followed. Q: Can international distributors contact MEDINDIA EXPORT? Yes. Eligible B2B pharmaceutical buyers and distributors can contact us for product availability and export-related inquiries. Q: What documents may be required? Depending on the destination, documentation may include commercial invoices, packing lists, shipping documents, product information, and applicable regulatory certificates. Request Product & Export Information For Golimumab (Simponi) 50 mg availability, export inquiries, documentation requirements, and destination-market information, contact: 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 MEDINDIA EXPORT Indian Pharmaceutical Exporter | Global B2B Pharmaceutical Trade